期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 178, 期 9, 页码 1936-1954出版社
WILEY
DOI: 10.1111/bph.14836
关键词
-
资金
- Deutsche Forschungsgemeinschaft [HE 5208/2-3, TA1154/2-1, TA1154/1-1]
- Weston Park Cancer Charity [CA163]
- University of Sheffield
- University of Lyon
- Institut National de la Sant et de la Recherche Mdicale [ASC17018CSA]
Bone metastases are common complications in patients with advanced cancer and current treatments are palliative. Research suggests that non-coding RNAs may play a crucial role in bone metastasis formation, offering potential therapeutic targets and biomarkers for improved treatment outcomes.
Bone metastases are frequent complications in patients with advanced cancer, which can be fatal or may rapidly impede the quality of life of patients. Current treatments for patients with bone metastases are palliative. Therefore, a better understanding of the molecular mechanisms that precede the overt development of skeletal lesions could lead to better therapeutic interventions. In this review, we present evidence that non-coding RNAs (ncRNAs) such as long ncRNAs, microRNAs, and circular RNAs are emerging as master regulators of bone metastasis formation. We highlight potential opportunities for the therapeutic targeting of ncRNAs. Furthermore, we discuss the possibility that ncRNAs may be used as biomarkers in the context of bone metastases, which might provide insight for improving the response to current bone-targeting therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据